Drugs / 3Fluart
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03833271 | Oct 2018 → Sep 2019 | juvenile idiopathic arthritis | University of Pecs | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03448705 Comparator | Jan → Apr 2018 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3Fluart | “participants are immunized with influenza (3Fluart) vaccine.” NCT03833271 ↗ |
| Known as | 3Fluart suspension for injection | “3Fluart suspension for injection” NCT03448705 ↗ |
| Modality | Vaccine | “influenza vaccine (whole virion, inactivated, adjuvanted)” NCT03448705 ↗ |
| Route | Intramuscular | “Route of administration: intramuscular” NCT03448705 ↗ |